Q4 2026
Next results · Q4 2026Projected
Feb 24, after the close
Wed, Feb 24, 2027in 99 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Feb 16 – Mar 1
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $255.10M
- Revenue, change from a year earlier: Q3 2026 −8.4%, Q2 2026 −5.2%, Q1 2026 +4.1%, Q4 2025 +88.1%
- Net income
- -$84.60M
- Net income, change from a year earlier: Q3 2026 +13.3%, Q2 2026 n/m, Q1 2026 +191.7%, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 +19.5%, Q2 2026 n/m, Q1 2026 +196.4%, Q3 2025 n/m
Results day
Typical moveA typical move of 8.1% either way
Up after 6 of 12, down after 6.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: +21.3% after Q2 2025.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
When it reports
- Usual day
- Wednesday
- 5 of its last 8
- Session
- after the close
- After quarter end
- 35 to 49 days
- 10-Q filed
- 30 to 37 days
- over its last 8
- 10-K filed
- 50 to 57 days
- over its last 8
Based on 8 prior 10-K filings.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR